Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

Firms / Eir Partners

Eir Partners

Hybrid manager · probableunsizedUS
Classification
Class
Hybrid managerprobable, confidence 65%
Basis
R4: Private Equity Funds are 0 of 1 distinct vehicles; hedge, securitized or liquidity vehicles 0
Size band
unsizeddefined by: no Private Equity Fund GAV on a filing from 2021 or later
Classification history (1)
  1. Sep 13, 2026
    Hybrid manager (probable, 65%, cls-pe-1)
    R4: Private Equity Funds are 0 of 1 distinct vehicles; hedge, securitized or liquidity vehicles 0
Regulatory footprint (Form ADV)
Adviser type
unknown
Form ADV filings
unknown
RAUM
unknownregulatory assets under management of the adviser; not dry powder, not a fund size
PE funds, latest filing
unknown
PE fund GAV, latest filing
unknownreported gross assets (Form ADV), not fund size
All private fund GAV
unknownevery private fund type, latest filing
2024 PE fund GAV
unknownsum over funds typed Private Equity Fund with a 2024 or later as-of date
PE share of funds, lifetime
unknown
Employees
unknown
Stated criteria beside observed behaviour
2 observed deals
Stated by the firm
Sectors
not stated or not yet read
Geography
not stated or not yet read
Revenue
not stated or not yet read
EBITDA
not stated or not yet read
Enterprise value
not stated or not yet read
Equity check
not stated or not yet read
Control
not stated or not yet read
Thesis
not stated or not yet read
Observed from deals on record
roles
unknown 1, platform 1
period
to 2026-09-09, from 2026-05-13, undated holdings 0, dated observations 4
window
last 2026-09-09, first 2026-05-13
control
control 1, unknown 1
companies
2
geography
investments
2
seller kinds
transactions
2
cadence by year
2026 platforms 1, other deals 1
platform add on
add ons 0, platforms 1, add ons per platform unknown
sector known for
2
disclosed value usd
n 0
sector distribution
count 1, share unknown, value life sciences, examples QuartzBio, count 1, share unknown, value software, examples Accumulus Technologies
holding period years
n 0
repeat counterparties
subsector distribution
count 1, share unknown, value life sciences, examples QuartzBio, count 1, share unknown, value vertical software, examples Accumulus Technologies

2 companies on the graph (2 transactions); most in life sciences (1); 1 platforms and 0 add-ons; observed 2026 to 2026

Funds
0 on record
No fund collected for this firm yet. Funds arrive from Form ADV Schedule D 7.B.(1) and Form D filings.
Team
1 current, 0 former
Managing partner (1)
Portfolio
2 relationships, 1 platforms, 0 add-ons
CompanyRoleStatusInvestedHeldPartnerSource
Accumulus TechnologiesPlatformactiveSep 9, 2026
transaction announcement
0 monthsBrett Carlson (confirmed)Fact Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
QuartzBioRole unknownactiveMay 13, 2026
transaction announcement
4 monthsBrett Carlson (confirmed)Fact Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
Transactions
3 on record
DateTypeTargetThis firm’s roleSource
Sep 9, 2026Platform acquisitionAccumulus TechnologiesSponsor (confirmed)globenewswire.com
May 13, 2026Growth investmentQuartzBioSponsor (confirmed)prnewswire.com
Aug 22, 2019Platform acquisitionOntario SystemsFinancial adviser (confirmed)newmountaincapital.com
Placement agents, lenders, advisers and co-investors
3 relationships
Financial advisers (3)
  • Bourne Partners 1 shared · one time · last May 13, 2026
  • TripleTree LLC 1 shared · one time · last Sep 9, 2026
  • EP Securities 1 shared · one time · last Sep 9, 2026
LP commitments
0 disclosed
No LP commitment collected yet. An LP edge needs a public disclosure with a quote, such as a pension plan’s report or an announcement naming the LP.
Events
2 most recent
  1. Sep 9, 2026
    Accumulus Technologies Announces Acquisition by Eir Partners to Accelerate Next Phase of Growth
  2. May 13, 2026
    QuartzBio Secures Growth Investment from Eir Partners to Accelerate Clinical Trial Intelligence